HC
PMN icon

Hara Capital’s ProMIS Neurosciences PMN Stock Holding History

Hara Capital’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,177
Closed -$44.1K – 303
2024
Q2 		$44.1K Hold
1,177
– – 0.03% 134
2024
Q1 		$56.2K Buy
+1,177
New +$58.3K 0.03% 133

Other funds holding PMN

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $9.19B AUM 25.65% 1-Year Est. Return

Hara Capital's PMN Position: Q3 2024 in Review

Hara Capital sold out of ProMIS Neurosciences (PMN) in Q3 2024, closing a stake of 1,177 shares — an estimated $44.1K sold.

Hara Capital first reported a position in PMN in Q1 2024 and held it in 2 quarters. The position peaked at $56.2K in Q1 2024. 17 funds tracked by Wall St. Rank hold PMN as of Q3 2024.

  • Hara Capital reported no remaining ProMIS Neurosciences position as of Q3 2024 after selling out during the quarter.
  • Hara Capital sold 1,177 ProMIS Neurosciences shares in Q3 2024, an estimated $44.1K.
  • Hara Capital first reported a position in ProMIS Neurosciences in Q1 2024 and held it in 2 quarters.
  • Hara Capital's ProMIS Neurosciences position peaked at $56.2K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q3 2024.

Based on Hara Capital's 13F filing for Q3 2024, filed 31 Oct 2024.